DC ChemicalsChemicals for Life Science
sales@dcchemicals.com

DC82115 · Updated 24 October 2026

BAMP-TK-12
Formulation & Performance

This edition organizes the previously reviewed, source-linked product record. It is not a new independent review of every paper or supporting file. Reported and calculated values retain their original labels.

Literature-reported formulation composition

ComponentReported mass ratio (w/w)Role
BAMP-TK-1216Ionizable lipid
Cholesterol4Sterol
DOPE4Helper phospholipid
DSPE-PEG20001PEG lipid
Reported ratio sum25Original ratio retained
Formulation calculator unavailable. A calculation is not enabled where component molecular weights or a fixed molar recipe are unverified. The 800:200:200:50 microgram inputs are 16:4:4:1 by mass, not mol%. The in vivo recipe lists three component names but four weights (4:1:1:2); it is not substituted here. Obtain and verify the complete composition and component molecular weights before planning component quantities.
Not reported in the cited article
15:1
Assembly: 200 mM sodium acetate pH 5.2. RNA complexation: 25 mM sodium acetate pH 5.2, 15 min.
RFP mRNA
In vitro cell transfection
100 ng RNA with 1.5 micrograms formulated LNP per well
HeLa cells
Thin-film preparation; dissolve in ethanol/200 mM sodium acetate (9:1); dropwise addition into acetate containing PEG lipid; dialyse against PBS for 2 h.

Literature-reported performance for the cited formulation

Literature-reportedUp to 95%RFP mRNA, in vitro; separate from DUF5 mouse studies · 48 hMain PDF p.2 and Fig.2; Methods pp.8-9
Literature-reported9.27TNS assay; formulation-specificMain PDF p.3; SI Fig.S5
Literature Data DisclaimerAll formulation parameters and performance values shown in this section are derived from the cited publication and are provided for reference only. These results were obtained using the specific materials, formulation process, cargo, dose, analytical method, model and administration route described in that study. Unless otherwise stated, the data were not generated or independently verified by DC Chemicals. DC Chemicals supplies the lipid compound only and does not guarantee that customers will reproduce the reported LNP properties or biological performance.

The administration route shown above was used in the cited study and is not a clinical-use instruction or recommendation by DC Chemicals.
Cited literature for this formulation and performance datasetA Combinatorial Library of Biodegradable Lipid Nanoparticles Preferentially Deliver mRNA. DOI: 10.1002/adfm.202204947 DOI: 10.1002/adfm.202204947
The 800:200:200:50 microgram inputs are 16:4:4:1 by mass, not mol%. The in vivo recipe lists three component names but four weights (4:1:1:2); it is not substituted here.

Primary article